Phenotypic Correction of Diabetic Mice by Adenovirus-Mediated Glucokinase Expression

Diabetes

Volumn 50, Issue 10, 2001, Pages 2287-2295

  Desai, Urvi J ^a   Slosberg, Eric D ^b   Boettcher, Brian R ^b   Caplan, Shari L ^b   Fanelli, Barbara ^b   Stephan, Zouhair ^b   Gunther, Vicky J ^a   Kaleko, Michael ^a   Connelly, Sheila ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOKINASE; GLYCOGEN; INSULIN; TRIACYLGLYCEROL;

ADENOVIRUS; ANIMAL; ARTICLE; BLOOD; C57BL MOUSE; DIABETES MELLITUS; DIET RESTRICTION; EATING; ENZYMOLOGY; GENE EXPRESSION; GENE TRANSFER; GENE VECTOR; GENETICS; GLUCOSE BLOOD LEVEL; HUMAN; LIVER; MALE; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY;

ADENOVIRIDAE; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS; EATING; FASTING; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GLUCOKINASE; GLYCOGEN; HUMANS; INSULIN; LIVER; MALE; MICE; MICE, INBRED C57BL; PHENOTYPE; TRIGLYCERIDES;

EID: 0035490888     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.10.2287     Document Type: Article

References (31)

1. Iynedjian PB: Mammalian glucokinase and its gene. Biochem J 293:1-13, 1993
2. Printz R, Magnuson MA, Granner DK: Mammalian glucokinase. Annu Rev Nutr 13:463-486, 1993
3. Matchinsky FM: A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes 45:223-241, 1996
4. Jetton TL, Liang Y, Pettepher CC, Zimmerman EC, Cox FG, Horvath K, Matschinsky FM, Magnuson MA: Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut. J Biol Chem 269:3641-3654, 1994
5. Terauchi Y, Sakura H, Yasuda K, Iwamoto K, Takahashi N, Ito K, Kasai H, Suzuki H, Ueda O, Kamada N, Jishage K, Komeda K, Noda M, Kanazawa Y, Taniguchi S, Miwa I, Akanuma Y, Kodama T, Yazaki Y, Kadowaki T: Pancreatic β-cell specific targeted disruption of glucokinase gene. Diabetes mellitus due to defective insulin secretion to glucose. J Biol Chem 270:30253-30250, 1995
6. Grupe A, Hultgren B, Ryan S, Ma YH, Bauer M, Stewart TA: Transgenic knockouts reveal a critical requirement for pancreatic beta cell glucokinase in maintaining glucose homeostasis. Cell 83:69-78, 1995
7. Bali D, Svetlanov A, Lee H, Fusco-DeMane D, Leiser M, Li B, Barzilai N, Surana M, Hou H, Fleischer N, DePinho R, Rossetti L, Efrat S: Animal model for maturity-onset diabetes of the young generated by disruption of the mouse glucokinase gene. J Biol Chem 270:21464-21467, 1995
8. Postic C, Shiota M, Niswender K, Jetton T, Chen Y, Moatos M, Shelton K, Linder J, Cherrington A: Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic β-cell-specific gene knock-outs using cre-recombinase. J Biol Chem 274:305-315, 1999
9. Rossetti L, Chen W, Hu M, Hawkins M, Burzilai N, Efrat S: Abnormal regulation of HGP by hyperglycemia in mice with a disrupted glucokinase allele. Am J Physiol 273:E743-E750, 1997
10. Niswender K, Shiota M, Postic C, Cherrington AD, Magnuson MA: Effects of increased glucokinase gene copy number on glucose homeostasis and hepatic glucose metabolism. J Biol Chem 272:22570-22575, 1997
11. Ferre T, Pujol A, Efren R, Bosch F, Valera A: Correction of diabetic alterations by glucokinase. Proc Natl Acad Sci U S A 93:7225-7230, 1996
12. Hariharan N, Farrelly D, Hagan D, Hillyer D, Arbeeny C, Sabrah T, Treloar A, Brown K, Kalinowski S, Mookhtiar K: Expression of human hepatic glucokinase in transgenic mice liver results in decreased glucose levels and reduced body weight. Diabetes 46:11-16, 1997
13. Burke CV, Buettger CW, Davis EA, McClane SJ, Matschinsky FM, Raper SE: Cell-biological assessment of human glucokinase mutants causing maturity-onset diabetes of the young type 2 (MODY-2) or glucokinase-linked hyperinsulinaemia (GK-HI). Biochem J 342:345-352, 1999
14. Smith TA, Mehaffey MG, Kayda DB, Saunders JM, Yei S, Trapnell BC, McClelland A, Kaleko M: Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nat Genet 5:397-402, 1993
15. Connelly S, Mount J, Mauser A, Gardner JM, Kaleko M, McClelland A, Lothrop CD Jr: Complete short-term correction of canine hemophilia A by in vivo gene therapy. Blond 88:3846-3853, 1996
16. Brann T, Kayda D, Lyons RM, Shirley P, Roy S, Kaleko M, Smith T: Adenoviral vector-mediated expression of physiologic levels of human factor VIII in non-human primates. Hum Gene Ther 10:2999-3011, 1999
17. O'Doherty RM, Lehman DL, Télémaque-Potts S, Newgard CB: Metabolic impact of glucokinase overexpression in the liver. Lowering of blood glucose in fed rats is accompanied by hyperlipidemia. Diabetes 48:2022-2027, 1999
18. Jiménez-Chilarón JC, Newgard CB, Gómez-Foix AM: Increased glucose disposal induced by adenovirus-mediated transfer of glucokinase to skeletal muscle in vivo. FASEB J 13:2153-2160, 1999
19. Seoane J, Barberà A, Télémaque-Potts S, Newgard CB, Guinovart JJ: Glucokinase overexprossion restores glucose utilization and storage in cultured hepatocytes from male Zucker diabetic fatty rats. J Biol Chem 274:31833-31838, 1999
20. Surwit RS, Feinglos MN, Rodin J, Sutherland A, Petro AE, Opara EC, Kuhn CM, Rebuffe-Scrive M: Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 44:645-651, 1995
21. Tanizawa Y, Koranyi LI, Welling CM, Permutt MA: Human liver glucokinase gene: cloning and sequence determination of two alternatively spliced cDNAs. Proc Natl Acad Sci U S A 88:7294-7297, 1991
22. Gorziglia MI, Kadan MJ, Yei S, Lim J, Lee GM, Luthra R, Trapnell BC: Elimination of both E1 and E2a from adenovirus vectors further improves prospects for in vivo human gene therapy. J Virol 6:4173-4178, 1996
23. Sauer B, Henderson N: Site specific recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc Natl Acad Sci U S A 85:5166-5170, 1988
24. Mittereder N, March KL, Trapnell BC: Evaluation of the concentration and bioactivity of adenovinis vectors for gene therapy. J Virol 70:7498-7509, 1996
25. Connelly S, Smith TAG, Dhir G, Gardner JM, Mehaffey MG, Zaret KS, McClelland A, Kaleko M: In vivo gene delivery and expression of physiological levels of functional human factor VIII in mice. Hum Gene Ther 6:185-193, 1995
26. Engelhardt JF, Litzky L, Wilson JM: Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a. Hum Gene Ther 5:1217-1229, 1994
27. Engelhardt JF, Ye X, Doranz B, Wilson JM: Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci U S A 91:0196-6200, 1994
28. Yang Y, Nunes FA, Berencsi K, Gonczol E, Engelhardt JF, Wilson JM: Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat Genet 7:362-369, 1994
29. Connelly S, Andrews J, Gallo A, Kayda D, Qian J, Hoyer L, Kadan M, Gorziglia M, Trapnell B, McClelland A, Kaleko M: Sustained phenotypic correction of murine hemophilia A by in vivo gene therapy. Blood 91:3273-3281, 1998
30. Shiota M, Postic C, Pujimoto Y, Jetton TL, Dixon K, Pan D, Grimsby J, Grippo JE, Magnuson MA, Cherrington AD: Glucokinase gene locus transgenic mice are resistant to the development of obesity-induced type 2 diabetes. Diabetes 50:622-629, 2001
31. Kochanek S: High capacity adenoviral vectors for gene transfer and somatic gene therapy. Hum Gene Ther 10:2461-2469, 1999